Melanie Aikebuse

An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care

P. Valery, J. O’Beirne, K. Hayward, 2022, Diabetic medicine : a journal of the British Diabetic Association.

Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes

S. McPhail, K. Irvine, P. Valery, 2022, BMC Health Services Research.

Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists.

K. Irvine, P. Valery, K. Hayward, 2023, Annals of hepatology.